Literature DB >> 3593407

Effects of methotrexate and other antifolates on the growth and dihydrofolate reductase activity of Leishmania promastigotes.

D A Scott, G H Coombs, B E Sanderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593407     DOI: 10.1016/0006-2952(87)90508-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  5 in total

1.  Increased transport of pteridines compensates for mutations in the high affinity folate transporter and contributes to methotrexate resistance in the protozoan parasite Leishmania tarentolae.

Authors:  C Kündig; A Haimeur; D Légaré; B Papadopoulou; M Ouellette
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Antileishmanial activities of 2,4-diaminoquinazoline putative dihydrofolate reductase inhibitors.

Authors:  J D Berman; M King; N Edwards
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters.

Authors:  Shraddha Kumari; Pragya Misra; Rati Tandon; Mukesh Samant; Shyam Sundar; Anuradha Dube
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

4.  Functional analysis of Leishmania major cyclophilin.

Authors:  Vyacheslav Yurchenko; Zhu Xue; Barbara Sherry; Michael Bukrinsky
Journal:  Int J Parasitol       Date:  2007-10-10       Impact factor: 3.981

5.  Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.

Authors:  Reema Gupta; Vikash Kumar; Pramod Kumar Kushawaha; Chandradev Pati Tripathi; Sumit Joshi; Amogh Anant Sahasrabuddhe; Kalyan Mitra; Shyam Sundar; Mohammad Imran Siddiqi; Anuradha Dube
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.